Current Status of Metabolomic Biomarker Discovery: Impact of Study Design and Demographic Characteristics
Widespread application of omic technologies is evolving our understanding of population health and holds promise in providing precise guidance for selection of therapeutic interventions based on patient biology. The opportunity to use hundreds of analytes for diagnostic assessment of human health co...
Main Authors: | Vladimir Tolstikov, A. James Moser, Rangaprasad Sarangarajan, Niven R. Narain, Michael A. Kiebish |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/10/6/224 |
Similar Items
-
Metabolomics in drug discovery: Restoring antibiotic pipeline
by: Faiza Azhar, et al.
Published: (2023-01-01) -
Integrated Metabolomic and Transcriptomic Analysis of Modified Nucleosides for Biomarker Discovery in Clear Cell Renal Cell Carcinoma
by: Daniel A. Mohl, et al.
Published: (2023-04-01) -
Editorial: Therapeutic and Diagnosis Target Discovery Based on Metabolomics
by: Linsheng Liu
Published: (2022-04-01) -
A Fecal-Microbial-Extracellular-Vesicles-Based Metabolomics Machine Learning Framework and Biomarker Discovery for Predicting Colorectal Cancer Patients
by: Fatma Hilal Yagin, et al.
Published: (2023-04-01) -
Simultaneous Quantitation and Discovery (SQUAD) Analysis: Combining the Best of Targeted and Untargeted Mass Spectrometry-Based Metabolomics
by: Bashar Amer, et al.
Published: (2023-05-01)